8-KThe WireRoutine
Shareholder Vote
Filed Jun 10, 2026 · 20d ago · Accession 0001193125-26-265858
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Maze Therapeutics, Inc.
- Ticker
- MAZE
- CIK
- 1842295
- Form type
- 8-K
- Filing date
- Jun 10, 2026
- Report date
- Jun 8, 2026
- Document
- d110541d8k.htm
- Size
- 147 KB